Fundraising FoxQiming Venture Partners — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.
BiotechSouth San Francisco, US
John F. Fowler(Executive Officer, Director)inChristopher J. Kirk(Executive Officer, Director)
BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)
Co-investorsBay City CapitalChiesi VenturesPappas CapitalQiming Venture Partners USASolasta VenturesCowen Healthcare Investments+1 more
HealthtechTewksbury, US
Lisa Mastromattei(Executive Officer)Lisa Wipperman Heine(Executive Officer)Sophia Wong(Executive Officer)Richard P. Geoffrion(Executive Officer, Director)
BoardMartien Van Osch(Director)Daniel Cole(Director)
Co-investors415 CapitalSaints CapitalXeraya CapitalForbionOxford Bioscience Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.